IRIS
COLLA, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 313
EU - Europa 245
AS - Asia 94
OC - Oceania 1
Totale 653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 312
IE - Irlanda 92
CN - Cina 86
SE - Svezia 50
IT - Italia 47
DE - Germania 22
FI - Finlandia 15
UA - Ucraina 6
IL - Israele 4
TR - Turchia 4
AT - Austria 3
BE - Belgio 2
PT - Portogallo 2
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
CZ - Repubblica Ceca 1
LU - Lussemburgo 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 653
Salva come PNG Salva come JPEG
Città #
Chandler 112
Dublin 89
Ashburn 29
Shanghai 21
Parma 20
Beijing 18
Princeton 13
Boardman 9
Bremen 9
Wilmington 9
Dearborn 8
Milan 8
Nanjing 7
Jacksonville 5
Kunming 5
San Mateo 5
Hefei 4
Houston 4
Izmir 4
New York 4
Shenyang 4
Changsha 3
Des Moines 3
Hebei 3
Helsinki 3
Jiaxing 3
Lviv 3
Nanchang 3
Rho 3
Vienna 3
Woodbridge 3
Ann Arbor 2
Bologna 2
Brussels 2
Hangzhou 2
Pescara 2
San Giuliano Milanese 2
Sassuolo 2
Tel Aviv 2
Tianjin 2
Washington 2
West Jordan 2
Casoria 1
Chengdu 1
Düsseldorf 1
Eboli 1
Fairfield 1
Frankfurt am Main 1
Geislingen an der Steige 1
Huizen 1
Luxembourg 1
Male Hostice 1
Manassas 1
Palermo 1
Perth 1
Redmond 1
Rockville 1
Santa Clara 1
Seattle 1
Sofia 1
Taizhou 1
Toronto 1
Turin 1
Viterbo 1
Waterford 1
Totale 462
Salva come PNG Salva come JPEG
Nome #
ILF2-YB1 Protein Interaction Modulates RNA Splicing to Induce Resistance to Chemotherapy in High Risk Multiple Myeloma 63
A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome 62
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 60
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma 60
Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome 58
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy 52
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma 48
ILF2-YB1 INTERACTION MODULATES RNA SPLICING TO INDUCE RESISTANCE TO DNA-DAMAGING AGENTS IN 1Q21-AMPLIFIED MULTIPLE MYELOMA 47
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function 41
PAF promotes stemness and radioresistance of glioma stem cells 39
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 35
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer 34
RNA processing: A new player of genomic instability in multiple myeloma 33
Down-regulation of EZH2 expression in myelodysplastic syndromes 26
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4) 18
Totale 676
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.495
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 1 8 2
2019/202070 18 15 1 1 2 4 7 4 2 8 7 1
2020/202116 0 1 0 10 1 0 1 0 1 1 1 0
2021/202264 7 0 0 0 2 0 1 5 11 6 1 31
2022/2023341 23 40 14 39 28 39 16 19 107 2 12 2
2023/2024122 9 8 3 4 12 20 39 6 10 11 0 0
Totale 676